{"id":"W3165800964","doi":"10.1136/annrheumdis-2021-eular.834","title":"OP0170 DECLINE IN FORCED VITAL CAPACITY (FVC) IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) WITH AND WITHOUT DYSPNOEA: DATA FROM THE SENSCIS TRIAL","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Cilag; David Geffen School of Medicine, University of California, Los Angeles; National Institutes of Health; Mitsubishi Tanabe Pharma Corporation; Fonds Wetenschappelijk Onderzoek; University College London; Seoul National University Hospital; Galápagos; Genentech; Vlaamse regering; Horizon Therapeutics; Savara Pharmaceuticals; Acceleron; Università degli Studi di Firenze; Hanyang University; Tel Aviv University; Mallinckrodt Pharmaceuticals; Immune Tolerance Network; GlaxoSmithKline; CSL Behring; Hospital for Special Surgery; Bristol-Myers Squibb; Eli Lilly and Company; United Therapeutics Corporation; Servier; Gilead Sciences; Seoul National University; Universitätsspital Zürich; Sanofi; Johns Hopkins University; Amgen; Pfizer","keywords":"Medicine; Vital capacity; Interstitial lung disease; Internal medicine; Nintedanib; Placebo; Pulmonary function testing; Spirometry; Diffusing capacity; Idiopathic pulmonary fibrosis; Lung; Asthma; Lung function; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001892344,0.001706232,0.003271856,0.0002644193,0.0002702085,0.001561666,0.000879986,0.001391991,0.005192377],"category_scores_gemma":[0.001845653,0.0004348176,0.003122603,0.0004666272,0.001085693,0.001430142,0.0005250861,0.003898548,0.0009979365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006313806,"about_ca_system_score_gemma":0.0007513945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001142377,"about_ca_topic_score_gemma":0.002684023,"domain_scores_codex":[0.9993697,0.0003227955,0.00004246805,0.0001009027,0.000051538,0.0001126074],"domain_scores_gemma":[0.9991149,0.0003142773,0.0001987036,0.00007497353,0.00006357965,0.0002335453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9549832,0.001086361,0.006782408,0.002326533,0.005656666,0.0001361892,0.00006338425,0.0006964703,0.001719745,0.0004269588,0.003391647,0.02273051],"study_design_scores_gemma":[0.892036,0.0516432,0.04258059,0.0003957674,0.007395808,0.0002066385,0.0001949761,0.0007958344,0.0004505457,0.0009214759,0.003304495,0.00007457063],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9647947,0.02428481,0.0003022054,0.001308548,0.0009513524,0.0003131451,0.002975348,0.00009615795,0.004973688],"genre_scores_gemma":[0.9819636,0.006919111,0.0003165153,0.001709601,0.0008004397,0.0003681757,0.004967678,0.00003195487,0.002922808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005192377,"threshold_uncertainty_score":0.01737022,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06800376561714887,"score_gpt":0.2852632062902529,"score_spread":0.217259440673104,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}